Does a Novel Mutagenic Process Target KMT2D Mutation in the Most Common First Event on the Path to Bladder Cancer?

Baker, Simon C; Mason, Andrew S; Southgate, Jennifer

Baker, Simon C; Mason, Andrew S; Southgate, Jennifer.

Afiliación

Baker SC; Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, UK. Electronic address: simon.baker@york.ac.uk.
Mason AS; Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, UK.
Southgate J; Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, York, UK.

Eur Urol ; 79(3): 435-436, 2021 03.

Article en En | MEDLINE | ID: mdl-33203550

Asunto(s)

Proteínas de Unión al ADN/genética; Proteínas de Neoplasias/genética; Neoplasias de la Vejiga Urinaria; Humanos; Mutación; Neoplasias de la Vejiga Urinaria/genética

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Proteínas de Unión al ADN / Proteínas de Neoplasias Límite: Humans Idioma: En Revista: Eur Urol Año: 2021 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google